
    
      The purpose of this study is to evaluate the Efficacy and the Safety of Monthly(RisenexM
      group) versus Weekly Oral risedronate(Risenexsplus group) with Vitamin D in compliance,
      improvement of vitaminD and BMD in Korean postmenopausal osteoporotic women(Phase IV)
    
  